Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2026-02-25 @ 3:46 AM
Study NCT ID:
NCT02134912
Status:
TERMINATED
Last Update Posted:
2020-02-20
First Post:
2014-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Sponsor:
SWOG Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2016-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-07
First Submit QC Date:
None
Study First Post Date:
2014-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-11
Results First Submit QC Date:
None
Results First Post Date:
2019-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-19
Last Update Post Date:
2020-02-20
Last Update Post Date Type:
ACTUAL